“Even though silencing the regulatory protein leads to an increase in pain sensitivity in the short term, it may well be that, thanks to the compensatory mechanism, we could gain a decrease in this sensitivity in the long term,” Yaron explains. “What we’ve discovered is a kind of ‘exposure therapy,’ whereby prolonged exposure to pain leads to desensitization to the pain-causing stimulus. A better understanding of this compensatory mechanism might facilitate future studies aimed at bringing relief to people who suffer from chronic pain.”
Also participating in the study were Dr. Irena Gokhman, Sapir Suissa and Dr. Andrew Kovalenko from Weizmann’s Biomolecular Sciences and Molecular Neuroscience Departments; Dr. Rebecca Haffner-Krausz from Weizmann’s Veterinary Resources Department; and Dr. Noa Wigoda, Dr. Ester Feldmesser and Dr. Shifra Ben-Dor from Weizmann’s Life Sciences Core Facilities Department.


